Please use this identifier to cite or link to this item:
|Title:||Treatment strategies for asthma: reshaping the concept of asthma management||Authors:||Papi, Alberto
Canonica, Giorgio Walter
|Keywords:||Anti-inflammatory treatment;Asthma;Disease control;Patient outcomes||Keywords Plus:||MILD PERSISTENT ASTHMA;DOUBLE-BLIND;INHALED CORTICOSTEROIDS;BUDESONIDE-FORMOTEROL;SINGLE INHALER;RELIEVER THERAPY;RESCUE TREATMENT;BUDESONIDE/FORMOTEROL;MAINTENANCE;EXACERBATIONS||Issue Date:||2020||Publisher:||BMC||Journal:||Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology||Abstract:||
Asthma is a common chronic disease characterized by episodic or persistent respiratory symptoms and airflow limitation. Asthma treatment is based on a stepwise and control-based approach that involves an iterative cycle of assessment, adjustment of the treatment and review of the response aimed to minimize symptom burden and risk of exacerbations. Anti-inflammatory treatment is the mainstay of asthma management. In this review we will discuss the rationale and barriers to the treatment of asthma that may result in poor outcomes. The benefits of currently available treatments and the possible strategies to overcome the barriers that limit the achievement of asthma control in real-life conditions and how these led to the GINA 2019 guidelines for asthma treatment and prevention will also be discussed.
|Appears in Collections:||Articles|
Show full item record
checked on Dec 7, 2021
WEB OF SCIENCETM
checked on Dec 2, 2021
Page view(s) 101
checked on Dec 8, 2021
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.